PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 24, 2000JAMA617 citations

Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction

View Full Paper
LMLaurie J. MorrisonPVP. Richard VerbeekAMAndrew McDonald

Key Points

  • To evaluate the effect of prehospital versus in-hospital thrombolysis on all-cause hospital mortality in patients experiencing an acute myocardial infarction.
  • Searched MEDLINE, EMBASE, Science Citation Index (1982–1999), Dissertation Abstracts, Current Contents, and trial registries with independent, blinded dual-reviewer abstraction.

Structured PICO

Does prehospital thrombolysis reduce all-cause hospital mortality in patients with acute myocardial infarction compared to in-hospital thrombolysis?

P
Population
6,434 patients with acute myocardial infarction (AMI) pooled from 6 randomized controlled trials
I
Intervention
Prehospital thrombolysis
C
Comparator
In-hospital thrombolysis
O
Outcome
All-cause hospital mortalityhard clinical

Prehospital administration of thrombolysis for acute myocardial infarction significantly reduces time to treatment and all-cause hospital mortality compared to in-hospital administration.

Abstract

CONTEXT: Early administration of thrombolysis for acute myocardial infarction (AMI) may improve survival if safely and appropriately delivered. No systematic reviews that have comprehensively examined this topic exist in the literature. OBJECTIVE: To perform a meta-analysis of randomized controlled trials of prehospital vs in-hospital thrombolysis for AMI measuring in-hospital mortality. DATA SOURCES: The Cochrane search strategy was used to search MEDLINE, EMBASE, and the Science Citation Index (1982-1999); Dissertation Abstracts (1987-1999); and Current Contents (1994-1999) for the terms thrombolysis, thrombolysis therapy, prehospital, and acute myocardial infarction. In addition, text and journal article bibliographies were hand searched, the National Institutes of Health Web site was reviewed, and primary authors and thrombolytic drug manufacturers were contacted for unpublished studies. STUDY SELECTION: Randomized controlled trials of prehospital vs in-hospital thrombolysis for AMI measuring all-cause hospital mortality were included. Two authors independently reviewed 175 citations by title, abstract, or complete article. After exclusion of 30 duplicate citations, 145 studies remained, of which 6 studies and 3 follow-up studies met the inclusion criteria. DATA EXTRACTION: Independent data abstraction by 2 reviewers blinded to the journal, title, and author was confirmed by consensus. Trial quality was independently assessed by 2 other coauthors, blinded to the author, title, journal, introduction, and discussion. DATA SYNTHESIS: The results of the 6 randomized trials (n=6434) were pooled and indicated significantly decreased all-cause hospital mortality among patients treated with prehospital thrombolysis compared with in-hospital thrombolysis (odds ratio, 0.83; 95% confidence interval, 0.70-0.98). Results were similar regardless of trial quality or training and experience of the provider. Estimated (SE) time to thrombolysis was 104 (7) minutes for the prehospital group and 162 (16) minutes for the in-hospital thrombolysis group (P=.007). CONCLUSIONS: Our meta-analysis suggests that prehospital thrombolysis for AMI significantly decreases the time to thrombolysis and all-cause hospital mortality. JAMA. 2000;283:2686-2692.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Morrison et al. (2000) studied this question.

synapsesocial.com/papers/6a7c9654e7df423ee14c7276https://doi.org/10.1001/jama.283.20.2686
Ask AI
Helpful
Bookmark
Share
View Full Paper